VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 455 filers reported holding VANECK VECTORS ETF TR in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $773,000 | -11.7% | 32,032 | +40.4% | 0.06% | -7.7% |
| Q1 2022 | $875,000 | +33.4% | 22,821 | +11.4% | 0.06% | +16.1% |
| Q4 2021 | $656,000 | +39.3% | 20,482 | +28.3% | 0.06% | +51.4% |
| Q3 2021 | $471,000 | -14.5% | 15,970 | -1.6% | 0.04% | -11.9% |
| Q2 2021 | $551,000 | +88.1% | 16,224 | +79.9% | 0.04% | +68.0% |
| Q1 2021 | $293,000 | +11.4% | 9,019 | +23.6% | 0.02% | +4.2% |
| Q4 2020 | $263,000 | -96.0% | 7,294 | -97.0% | 0.02% | -97.2% |
| Q3 2019 | $6,529,000 | +28.9% | 244,456 | +23.3% | 0.86% | +21.9% |
| Q2 2019 | $5,066,000 | +138.4% | 198,199 | +96.7% | 0.70% | +212.9% |
| Q4 2018 | $2,125,000 | +6.6% | 100,764 | +11.1% | 0.22% | +45.2% |
| Q1 2018 | $1,994,000 | +40.4% | 90,700 | +45.6% | 0.16% | -48.3% |
| Q1 2017 | $1,420,000 | – | 62,300 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |